Suppressive effects of liquid crystal compounds on the growth of U937 human leukemic monocyte lymphoma cells

Background The aim of this study was to evaluate the biological and pharmaceutical activities of 14 amphiphilic liquid-crystalline compounds (LCs), i.e, phenylpyrimidine derivatives possessing D-glucamine and cyanobiphenyl derivatives with a terminal hydroxyl unit.